Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

CellCept Warning Label Updated for Progressive Multifocal Leukoencephalopathy (PML) Risks

Filed June 30th, 2008 amy

According to a letter sent to healthcare providers, cases of Progressive Multifocal Leukoencephalopathy (PML), sometimes fatal, have been reported in patients treated with CellCept. PML is a disease of the central nervous system which usually leads to death or severe disability.

The letter states that on July jameshallison casino 8, 2007, Roche searched its global safety database for CellCept cases potentially associated with PML and found ten confirmed cases, plus seven possible cases. Of the seventeen cases, seven had a fatal outcome. Five improved, and five had an unknown outcome.

CellCept is used in organ transplants to help the patient’s body not reject the new organ.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!